Revvity Inc
RVTY: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$766.00 | Dntjshn | Lmrpzdb |
PerkinElmer Reports Strong Q1 Results Based on COVID-19 Tailwinds; No FVE Change
Narrow-moat PerkinElmer reported strong first-quarter results, delivering overall revenue of about $1.3 billion, beating our and FactSet consensus expectations on the top and bottom lines. Unsurprisingly, the company experienced another quarter of solid growth, nearly up 100% from 2020, mainly driven by the ongoing demand for its COVID-19-related testing solutions. We are maintaining our narrow moat rating and $106 fair value estimate.